Darou Pakhsh Pharmaceutical

What Darou Pakhsh Pharmaceutical does

Darou Pakhsh Pharmaceutical (شرکت کارخانجات داروپخش, legally Daroupakhsh Pharmaceutical Manufacturing Companies - Private Joint Stock Company) is Iran's largest and longest-established pharmaceutical manufacturer, founded in 1956 in cooperation with the British firm Allen & Hanburys (A&H) to supply 5 hospitals and 255 clinics. The company manufactures over 300 pharmaceutical products across twelve therapeutic categories — including contrast media, cardiovascular, gastrointestinal, anti-infective, CNS, endocrine/metabolic, dermatological, anesthesia, nutritional supplements, and infertility therapy agents — historically under license from Schering and M.S.D. Its Tehran Stock Exchange-listed manufacturing entity (publicly listed, ticker Daroupakhsh) operates from a main facility on the Tehran-Karaj highway and regional distribution centers, supplying Iran's hospitals, pharmacies, and clinics through both owned and partner distribution channels.

The business model is B2B pharmaceutical manufacturing: revenue is generated from sale of domestically produced generic and licensed drugs to institutional buyers across the Iranian healthcare system, with pricing regulated by Iran's Food and Drug Administration. The company holds GMP, GLP, ISO 9001-2008, and ISO 14001-2004 certifications, and maintains socially-owned status under the Social Security Investment Organization via its investment-holding subsidiary Tamin Pharmaceutical Investment Company (TPICO). It reports record-breaking monthly sales exceeding 1,000 billion tomans in late 2025 and has recently commissioned advanced filling machines developed with domestic Iranian knowledge, while exploring export channels via a Vietnamese trade delegation in 2025.

The go-to-market motion is enterprise field sales combined with event-driven engagement at major industry congresses (Iran Pharma Expo, National Radiology Congress, International Gynecology Congress). Distribution is executed through the company's own regional centers (e.g., Shiraz) and partner distributors (e.g., Hejrat Shiraz Distribution Company), serving a customer base effectively concentrated in the Iranian public and semi-public healthcare system given TPICO/Social Security Organization ownership.

Name

Darou Pakhsh Pharmaceutical

Legal name

شرکت کارخانجات داروپخش (سهامی خاص) (Daroupakhsh Pharmaceutical Manufacturing Companies - Private Joint Stock Company)

Website

https://dppharma.com

Company type

Public

Founded year

1956

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Darou Pakhsh Pharmaceutical is Iran's largest and oldest pharmaceutical manufacturer, producing 300+ products across 12 therapeutic categories and supplying hospitals, pharmacies, and clinics nationwide through its own distribution network and partner distributors.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical manufacturing
• Pharmaceutical distribution
• Generic medicines
• Therapeutic products
• Healthcare supply

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Product Sales: The company generates revenue primarily from the manufacture and sale of pharmaceutical products. It is a publicly listed company (سهامی عام — public joint stock company) on the Iranian stock exchange. Monthly sales have exceeded 1,000 billion tomans for consecutive months in late 2025, with record-breaking sales performance in Mehr 1404 (September–October 2025) and seven-month cumulative records.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Darou Pakhsh manufactures, supplies and distributes more than 300 pharmaceutical products across twelve therapeutic categories, including contrast media, cardiovascular agents, gastrointestinal agents, anti-infectives, analgesics, central nervous system agents, endocrine and metabolic agents, dermatological products, anesthesia, nutritional supplements, autonomic nervous system agents and miscellaneous preparations. The company also operates a nationwide distribution network serving hospitals, pharmacies and clinics across Iran through regional centres and contracted distributors.

Product overview

Darou Pakhsh Pharmaceutical is Iran's largest and oldest pharmaceutical manufacturing company, producing over 300 pharmaceutical products under license from international pharmaceutical companies such as Schering and M.S.D. The company's product portfolio encompasses twelve major therapeutic categories: Contrast Media (diagnostic imaging agents), Cardiovascular Agents, Gastrointestinal Agents, Anti-Infective and Antiparasitic Agents, Analgesics/Antipyretics/Anti-Inflammatory agents, CNS Agents (including antidepressants and antipsychotics), Endocrine and Metabolic Agents (including antidiabetics), Skin Care Agents, Anesthesia and Local Anesthesia, Nutritional Products/Vitamins/Dietary Supplements, Autonomic Nervous System Agents, and Infertility Therapy Adjuncts. The products are manufactured across various dosage forms including injectables, tablets, capsules, and ampoules. The company operates under GMP standards and serves the Iranian healthcare market through its distribution network.

Differentiator

Problem solved

Functional benefit

Products and services

• Contrast Media products Imaging and diagnostic contrast media manufactured by Darou Pakhsh for use in Iranian hospitals and diagnostic centres.
• Cardiovascular Agents Cardiovascular medicines produced and supplied by Darou Pakhsh for patients under treatment by Iranian cardiologists and hospitals.
• Gastrointestinal Agents Gastrointestinal pharmaceutical products manufactured and distributed by Darou Pakhsh for patients and gastroenterology prescribers across Iran.
• Anti-Infective Agents Antibiotic, antifungal and anti-infective preparations manufactured by Darou Pakhsh for prescription use in hospitals and pharmacies across Iran.
• Analgesic Agents Pain management pharmaceutical products manufactured and supplied by Darou Pakhsh to hospitals and pharmacies in Iran.
• CNS (Central Nervous System) Agents Central nervous system medicines produced by Darou Pakhsh for the Iranian healthcare market.
• Endocrine and Metabolic Agents Endocrine and metabolic pharmaceutical products manufactured by Darou Pakhsh and distributed across Iran for diabetes, hormone and metabolism treatment needs.
• Dermatological Products Dermatology pharmaceuticals manufactured and supplied by Darou Pakhsh for prescription and dispensing within Iran.
• Anesthesia Products Anesthetic pharmaceutical products manufactured by Darou Pakhsh for surgical and procedural use in Iranian hospitals.
• Nutritional Supplement Products Nutritional supplement pharmaceutical products manufactured by Darou Pakhsh and distributed to pharmacies and hospitals in Iran.
• Autonomic Nervous System Agents Autonomic nervous system pharmaceuticals manufactured and distributed by Darou Pakhsh for hospital and pharmacy channels in Iran.
• Miscellaneous Pharmaceutical Preparations Catch-all category of additional pharmaceutical preparations produced by Darou Pakhsh beyond its primary eleven therapeutic lines, distributed across Iran.

Quantifiable outcome

• Over 300 pharmaceutical products manufactured and distributed across Iran
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Hejrat Shiraz Distribution Company — شرکت پخش هجرت شیرازminorChannel Partner/ Reseller/ DistributorThe CEO of Darou Pakhsh visited Hejrat Shiraz distribution company as part of regular oversight of the distribution network, indicating an ongoing commercial distribution partnership.

Scale indicators5 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with broad therapeutic portfolio across primary care and specialty categories, serving MENA institutional and retail channels. Comparable to Darou Pakhsh in regional positioning, multi-category manufacturing footprint, and focus on MENA healthcare demand.
• Tabuk Pharmaceuticals: Saudi pharmaceutical company manufacturing a wide range of branded generic medicines for regional markets. Comparable to Darou Pakhsh in its focus on domestic/regional manufacturing for a multi-therapeutic portfolio.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi-listed pharmaceutical manufacturer producing branded generics and licensed products across multiple therapeutic areas with strong government and institutional channel access. Closely comparable to Darou Pakhsh as a publicly-traded MENA pharma manufacturer with diversified portfolio.

Broad incumbents

• Cipla: Major Indian pharmaceutical manufacturer with extensive MENA and emerging market presence across respiratory, cardiovascular, anti-infectives and other therapeutic categories. Comparable in scope of multi-category branded generic manufacturing.
• Hikma Pharmaceuticals: Jordan-headquartered global pharmaceutical company with strong MENA footprint and broad branded generics portfolio. Comparable to Darou Pakhsh as a larger regional incumbent serving similar institutional and pharmacy channels across multiple therapeutic areas.
• GlaxoSmithKline (GSK): Global pharmaceutical major and historical parent of Allen & Hanburys, the original founding partner of Darou Pakhsh. Relevant broad incumbent comparator given the historical licensing relationship and shared product categories.
• Merck & Co. (MSD): Global pharmaceutical major and historical Darou Pakhsh licensor whose products are still manufactured by the company. Broad incumbent comparable in original innovator-pharma positioning and therapeutic breadth.
• Dr. Reddy's Laboratories: Indian-headquartered global pharmaceutical manufacturer producing branded and generic medicines across therapeutic categories. Comparable in manufacturing breadth and active participation in emerging and regulated markets.
• Aurobindo Pharma: Large Indian pharmaceutical manufacturer with global generics portfolio spanning multiple therapeutic areas. Comparable to Darou Pakhsh in scale of multi-category finished dosage manufacturing and licensing heritage.
• Bayer (Schering): Global pharmaceutical major that acquired Schering, a historical licensor whose products were manufactured by Darou Pakhsh. Broad incumbent relevant both as legacy technology partner and category competitor in women's health, contrast media, and specialty therapeutics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Darou Pakhsh Pharmaceutical